Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BEA 2180 BR in Healthy Male Subjects
Clinical trial NCT02263976 · COMPLETED
Trial details
- NCT number
- NCT02263976
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2004-06-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.